Resveratrol-Induced AMP-Activated Protein Kinase Activation Is Cell-Type Dependent: Lessons from Basic Research for Clinical Application

Despite the promising effects of resveratrol, its efficacy in the clinic remains controversial. We were the first group to report that the SIRT1 activator resveratrol activates AMP-activated protein kinase (AMPK) (Diabetes 2005; 54: A383), and we think that the variability of this cascade may be res...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Fan, Weikel, Karen A., Cacicedo, Jose M., Ido, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537865/
https://www.ncbi.nlm.nih.gov/pubmed/28708087
http://dx.doi.org/10.3390/nu9070751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537865/
https://www.ncbi.nlm.nih.gov/pubmed/28708087
http://dx.doi.org/10.3390/nu9070751

Ejemplares similares